Cited 13 times in
Orthotopic liver transplantation after the combined use of locoregional therapy and sorafenib for advanced hepatocellular carcinoma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 주동진 | - |
dc.contributor.author | 최기홍 | - |
dc.contributor.author | 한광협 | - |
dc.contributor.author | 김도영 | - |
dc.contributor.author | 김승업 | - |
dc.contributor.author | 박준용 | - |
dc.contributor.author | 성진실 | - |
dc.contributor.author | 신혜선 | - |
dc.contributor.author | 안상훈 | - |
dc.contributor.author | 유은진 | - |
dc.contributor.author | 전재윤 | - |
dc.date.accessioned | 2014-12-18T08:59:24Z | - |
dc.date.available | 2014-12-18T08:59:24Z | - |
dc.date.issued | 2013 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/87328 | - |
dc.description.abstract | Abstract: We herein report a patient with advanced hepatitis B virus-related hepatocellular carcinoma (HCC) beyond the Milan criteria. He underwent orthotopic liver transplantation after successful HCC downstaging that satisfied the University of California, San Francisco criteria, using concurrent chemoradiation therapy with a combination of repeated hepatic arterial infusion chemotherapy (HAIC) and sorafenib. A 52-year-old male was diagnosed with advanced hepatitis B virus-related HCC beyond the Milan criteria. He underwent concurrent chemoradiation therapy (50 Gy with 20 fractions over 5 weeks with HAIC using 5-fluorouracil at a dose of 500 mg/day, which was administered during the first and fifth weeks of radiation therapy) as an initial treatment modality. This was followed by the combined use of HAIC using 5-fluorouracil (500 mg/m2 for 5 hours on days 1–3) and cisplatin (60 mg/m2 for 2 hours on day 2) every 4 weeks (twelve cycles) and sorafenib (from the third to the twelfth cycle of HAIC) to treat the remaining HCC. Because a remarkable decrease in the tumor burden that satisfied the University of California, San Francisco criteria was observed after these combination treatments, the patient underwent orthotopic liver transplantation with curative aim and survived for 11 months without evidence of HCC recurrence. | - |
dc.description.statementOfResponsibility | open | - |
dc.relation.isPartOf | ONCOTARGETS AND THERAPY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.title | Orthotopic liver transplantation after the combined use of locoregional therapy and sorafenib for advanced hepatocellular carcinoma | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학) | - |
dc.contributor.googleauthor | Eun Jin Yoo | - |
dc.contributor.googleauthor | Hye Sun Shin | - |
dc.contributor.googleauthor | Seung Up Kim | - |
dc.contributor.googleauthor | Dong Jin Joo | - |
dc.contributor.googleauthor | Jun Yong Park | - |
dc.contributor.googleauthor | Gi Hong Choi | - |
dc.contributor.googleauthor | Do Young Kim | - |
dc.contributor.googleauthor | Sang Hoon Ahn | - |
dc.contributor.googleauthor | Jinsil Seong | - |
dc.contributor.googleauthor | Myung Joo Koh | - |
dc.contributor.googleauthor | Kwang-Hyub Han | - |
dc.contributor.googleauthor | Chae Yoon Chon | - |
dc.identifier.doi | 10.2147/OTT.S45602 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A03948 | - |
dc.contributor.localId | A04046 | - |
dc.contributor.localId | A04268 | - |
dc.contributor.localId | A00654 | - |
dc.contributor.localId | A01675 | - |
dc.contributor.localId | A01956 | - |
dc.contributor.localId | A02182 | - |
dc.contributor.localId | A02226 | - |
dc.contributor.localId | A02492 | - |
dc.contributor.localId | A03544 | - |
dc.contributor.localId | A00385 | - |
dc.relation.journalcode | J02422 | - |
dc.identifier.eissn | 1178-6930 | - |
dc.identifier.pmid | 23836988 | - |
dc.subject.keyword | concurrent chemoradiation | - |
dc.subject.keyword | downstaging | - |
dc.subject.keyword | hepatic arterial infusion chemotherapy | - |
dc.subject.keyword | hepatocellular carcinoma | - |
dc.subject.keyword | liver transplantation | - |
dc.subject.keyword | sorafenib | - |
dc.contributor.alternativeName | Joo, Dong Jin | - |
dc.contributor.alternativeName | Choi, Gi Hong | - |
dc.contributor.alternativeName | Han, Kwang Hyup | - |
dc.contributor.alternativeName | Kim, Do Young | - |
dc.contributor.alternativeName | Kim, Seung Up | - |
dc.contributor.alternativeName | Park, Jun Yong | - |
dc.contributor.alternativeName | Seong, Jin Sil | - |
dc.contributor.alternativeName | Shin, Hye Sun | - |
dc.contributor.alternativeName | Ahn, Sang Hoon | - |
dc.contributor.alternativeName | Yoo, Eun Jin | - |
dc.contributor.alternativeName | Chon, Chae Yoon | - |
dc.contributor.affiliatedAuthor | Joo, Dong Jin | - |
dc.contributor.affiliatedAuthor | Choi, Gi Hong | - |
dc.contributor.affiliatedAuthor | Han, Kwang Hyup | - |
dc.contributor.affiliatedAuthor | Kim, Seung Up | - |
dc.contributor.affiliatedAuthor | Park, Jun Yong | - |
dc.contributor.affiliatedAuthor | Seong, Jin Sil | - |
dc.contributor.affiliatedAuthor | Shin, Hye Sun | - |
dc.contributor.affiliatedAuthor | Ahn, Sang Hoon | - |
dc.contributor.affiliatedAuthor | Yoo, Eun Jin | - |
dc.contributor.affiliatedAuthor | Chon, Chae Yoon | - |
dc.contributor.affiliatedAuthor | Kim, Do Young | - |
dc.rights.accessRights | free | - |
dc.citation.volume | 6 | - |
dc.citation.startPage | 755 | - |
dc.citation.endPage | 759 | - |
dc.identifier.bibliographicCitation | ONCOTARGETS AND THERAPY, Vol.6 : 755-759, 2013 | - |
dc.identifier.rimsid | 32984 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.